protein · BEGINNER LESSON
CRABP1
CRABP1 stands for cellular retinoic acid-binding protein 1. It is a cytoplasm-localized retinoid-binding protein that can bind retinoic acid, a vitamin A derivative.
What CRABP1 is and what is measured
CRABP1 is the name of a protein encoded by the CRABP1 gene. Public studies describe it as a cellular retinoic acid-binding protein found in the cytoplasm, with binding activity for retinoic acid and other retinoid-related molecules. In research, scientists measure things such as where the protein is located, what it binds, and whether it appears more or less abundant in different tissues or disease samples. These measurements come from database annotation and proteomic profiling, not from a single direct test of every possible role.
[1] Integrated Pan-Cancer Analysis and Experimental ... [2] Region-Specific Proteomic Profiles of Extracellular Vesicles ...
How it works in cells
Retinoids are molecules derived from vitamin A. Retinoid-binding proteins help move and handle these molecules inside cells, which matters because retinoid signaling helps regulate cell differentiation, proliferation, and apoptosis; apoptosis means programmed cell death. CRABP1 is therefore part of the cellular machinery that can influence how retinoic acid is available in the cytoplasm. In breast cancer-related analyses, CRABP1 appears among retinoid-binding proteins linked to cancer biology, and it is also listed as a gene associated with several cancer types in a compiled table.
[1] Integrated Pan-Cancer Analysis and Experimental ... [3] Association of retinoids, retinoic acid receptors and ...
Where it has been observed
One proteomic study of retinal pigment epithelium and choroid explants found CRABP1 among proteins enriched in the peripheral region and associated with retinoid- and vitamin-binding terms. The same study notes that the retina pigment epithelium has a central role in retinoid metabolism through the visual cycle, which helps regenerate the visual chromophore 11-cis-retinal for photoreceptors. This places CRABP1 in a broader retinoid-handling environment, although the study does not prove a specific mechanism for CRABP1 by itself.
[2] Region-Specific Proteomic Profiles of Extracellular Vesicles ...
Limits of the evidence
The evidence here is mostly descriptive: gene and protein databases, pathway annotations, and proteomic comparisons. The cancer paper also reports predicted or compiled properties such as localization and gene-category labels, while the retinal study reports enrichment patterns from proteomics. These sources show association with retinoid biology, but they do not by themselves establish a full causal mechanism for CRABP1 in disease or vision.
[1] Integrated Pan-Cancer Analysis and Experimental ... [2] Region-Specific Proteomic Profiles of Extracellular Vesicles ... [3] Association of retinoids, retinoic acid receptors and ...
SEE THE IDEA
CRABP1 in retinoid handling
Retinoic acid is the molecule CRABP1 can bind.
A cytoplasmic retinoic acid-binding protein 1.
Retinoid signaling affects differentiation, proliferation, and apoptosis.
Found in cancer-focused analyses and retinal proteomics.
Retinoic acid can bind CRABP1, placing the protein between retinoid availability and larger cellular responses.
A simple view of how CRABP1 connects retinoic acid binding to broader retinoid biology, without proving a single disease mechanism.
TRY IT YOURSELF
Test your understanding
Choose an answer, then check the explanation.
PUT IT TOGETHER
Match each concept to its meaning
Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.
4 pairs to match
Sources and further reading
This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.